Literature DB >> 15725414

Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons.

Benoît Schaller1, Robert H Andres, Alexander W Huber, Morten Meyer, Alberto Pérez-Bouza, Angélique D Ducray, Rolf W Seiler, Hans R Widmer.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) is a potent survival factor for ventral mesencephalic (VM) dopaminergic neurons. Subpopulations of dopaminergic and non-dopaminergic VM neurons express the calcium-binding proteins calbindin (CB) and calretinin (CR). Characterization of the actions of GDNF on distinct subpopulations of VM cells is of great importance for its potential use as a therapeutic molecule and for understanding its role in neuronal development. The present study investigated the effects of GDNF on the survival and morphological differentiation of dopaminergic and non-dopaminergic neurons in primary cultures of embryonic day (E) 18 rat VM. As expected from our results obtained using E14 VM cells, GDNF significantly increased the morphological complexity of E18 CB-immunoreractive (CB-ir), tyrosine hydroxylase (TH)-ir, and CR-ir neurons and also the densities of CB-ir and TH-ir neurons. Interestingly, densities of E18 CR-ir neurons, contrarily to our previous observations on E14 CR-ir neurons, were significantly higher after GDNF treatment (by 1.5-fold). Colocalization analyses demonstrated that GDNF increased the densitiy of dopaminergic neurons expressing CR (TH+/CR+/CB-), while no significant effects were observed for TH-/CR+/CB- cell densities. In contrast, we found that GDNF significantly increased the total fiber length (2-fold), number of primary neurites (1.4-fold), number of branching points (2.5-fold), and the size of neurite field per neuron (1.8-fold) of the non-dopaminergic CR-expressing neurons (TH-/CR+/CB-). These cells were identified as GABA-expressing neurons. In conclusion, our findings recognize GDNF as a potent differentiation factor for the development of VM dopaminergic and non-dopaminergic CR-expressing neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15725414     DOI: 10.1016/j.brainres.2004.12.054

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Astrocyte, the star avatar: redefined.

Authors:  Pankaj Seth; Nitin Koul
Journal:  J Biosci       Date:  2008-09       Impact factor: 1.826

2.  Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

Authors:  Sara af Bjerkén; Heather A Boger; Matthew Nelson; Barry J Hoffer; Ann-Charlotte Granholm; Ingrid Strömberg
Journal:  Brain Res       Date:  2006-12-19       Impact factor: 3.252

3.  Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion.

Authors:  Angela Koelsch; Yongjia Feng; David J Fink; Marina Mata
Journal:  J Neurochem       Date:  2010-02-02       Impact factor: 5.372

4.  A synthetic five amino acid propeptide increases dopamine neuron differentiation and neurochemical function.

Authors:  O M Littrell; J L Fuqua; A D Richardson; J Turchan-Cholewo; E R Hascup; P Huettl; F Pomerleau; L H Bradley; D M Gash; G A Gerhardt
Journal:  Neuropeptides       Date:  2012-09-13       Impact factor: 3.286

5.  VGluT2 Expression in Dopamine Neurons Contributes to Postlesional Striatal Reinnervation.

Authors:  Willemieke M Kouwenhoven; Guillaume Fortin; Anna-Maija Penttinen; Clélia Florence; Benoît Delignat-Lavaud; Marie-Josée Bourque; Thorsten Trimbuch; Milagros Pereira Luppi; Alix Salvail-Lacoste; Pascale Legault; Jean-François Poulin; Christian Rosenmund; Raj Awatramani; Louis-Éric Trudeau
Journal:  J Neurosci       Date:  2020-09-14       Impact factor: 6.167

6.  Establishment of a survival and toxic cellular model for Parkinson's disease from chicken mesencephalon.

Authors:  Amparo Tolosa; Xiaolai Zhou; Björn Spittau; Kerstin Krieglstein
Journal:  Neurotox Res       Date:  2012-12-13       Impact factor: 3.911

Review 7.  Stem cell-based therapies for ischemic stroke.

Authors:  Lei Hao; Zhongmin Zou; Hong Tian; Yubo Zhang; Huchuan Zhou; Lei Liu
Journal:  Biomed Res Int       Date:  2014-02-26       Impact factor: 3.411

8.  Characterization of fetal antigen 1/delta-like 1 homologue expressing cells in the rat nigrostriatal system: effects of a unilateral 6-hydroxydopamine lesion.

Authors:  Rémy Liechti; Angélique D Ducray; Pia Jensen; Stefano Di Santo; Stefanie Seiler; Charlotte H Jensen; Morten Meyer; Hans Rudolf Widmer
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

Review 9.  The Non-Survival Effects of Glial Cell Line-Derived Neurotrophic Factor on Neural Cells.

Authors:  Daniel Cortés; Oscar A Carballo-Molina; María José Castellanos-Montiel; Iván Velasco
Journal:  Front Mol Neurosci       Date:  2017-08-22       Impact factor: 6.261

10.  Regulated expression of lentivirus-mediated GDNF in human bone marrow-derived mesenchymal stem cells and its neuroprotection on dopaminergic cells in vitro.

Authors:  Wei-Hua Yang; Chun Yang; Yue-Qiang Xue; Tao Lu; Jakob Reiser; Li-Ru Zhao; Wei-Ming Duan
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.